Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
2,601	84.13995	1	female	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	>$50k	0	51,665	23,915.7656	28,919.6875	65	white	48	68	0.084	0.031998	3	0	0	no	0.25	0.25	no dnr	6	70	2.5	108	15	36.69531	null	2	0.899902	0.399963	137	null	155	11	3,000	null	0	<2 mo. follow-up	0
2,602	41.314	1	female	0	10	397	CHF	COPD/CHF/Cirrhosis	3	11	under $11k	0	10,240	5,688.7188	5,839.58984	9.5	white	24.398438	23	0.881958	0.802979	1	0	0	no	0.95	0.8	no dnr	10	77	5.699219	60	20	36.09375	null	3.899902	0.599976	2.799805	139	null	115	70	1,200	2	null	null	1.838867
2,603	68.81598	1	male	1	16	16	CHF	COPD/CHF/Cirrhosis	5	16	$25-$50k	0	22,629	12,613.125	11,510.2734	16.333328	white	26.898438	39	0.75293	0.608887	1	1	0	no	0.9	0.7	dnr after sadm	14	72	18.398438	68	16	35.89844	null	1.699951	null	0.699951	137	null	68	15	310	2	3	<2 mo. follow-up	3
2,604	53.46997	0	female	0	12	941	ARF/MOSF w/Sepsis	ARF/MOSF	5	12	under $11k	0	23,618	10,149.8594	15,127.375	19	white	31.296875	41	0.73291	0.649902	1	1	0	no	0.35	0.27	no dnr	12	77	5.699219	60	20	35.59375	548	3.399902	0.299988	2.899902	136	7.299805	54	63	780	1	0	SIP>=30	0
2,605	57.35498	1	male	0	16	44	Lung Cancer	Cancer	2	10	under $11k	0	27,340	14,559.7422	18,433.9688	15.666664	white	28.898438	23	0.431946	0.125	1	0	0	metastatic	0.9	0.5	dnr after sadm	1	77	8.199219	70	25	36.09375	null	null	0.399963	0.699951	132	null	94	10	1,550	3	1	<2 mo. follow-up	1
2,606	79.15094	1	female	0	36	102	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	null	9	53,562	null	null	19.25	white	23.398438	30	0.657959	0.55896	2	1	1	yes	0.3	0.3	dnr after sadm	5	123	12.5	67	25	36.09375	170	null	null	1.899902	138	7.449219	92	27	2,170	null	5	adl>=4 (>=5 if sur)	5
2,607	77.133	0	female	0	6	939	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	7,707	3,549.8262	3,900.88867	14	white	12.699219	14	0.896973	0.860962	1	0	0	no	0.9	0.85	no dnr	6	103	10.5	44	6	37.89844	214	null	0.5	2.699707	145	7.399414	440	81	615	1	0	no(M2 and SIP pres)	0
2,608	63.72299	1	male	0	9	52	Cirrhosis	COPD/CHF/Cirrhosis	2	9	under $11k	0	12,741	6,802.207	6,108.97656	17.5	white	26.5	55	0.640991	0.459961	1	0	0	no	0.6	0.4	dnr after sadm	4	107	12	80	25	35.59375	null	null	null	1.099854	136	null	181	18	5,800	0	0	<2 mo. follow-up	0
2,609	72.30896	0	male	0	7	939	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	$11-$25k	0	32,851	14,498.5859	23,926.0781	13	white	25.296875	31	0.660889	0.563965	4	0	0	yes	0.75	0.5	no dnr	7	77	11.199219	80	20	36.09375	476.1875	2.5	0.599976	4.199219	147	7.40918	77	107	400	0	0	no(M2 and SIP pres)	0
2,610	56.20798	0	female	0	19	939	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	58,257	36,612.6875	36,632.8125	19.333328	white	25.699219	31	0.723999	0.638916	5	0	0	yes	0.6	0.5	no dnr	19	49	18.796875	120	44	36.39844	173.46875	3.599609	null	1.899902	135	7.429688	92	46	1,520	null	null	null	2.831543
2,611	90.448	1	female	0	11	872	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	9	23,279	14,248.1094	14,757.8672	23	white	24.5	23	0.659912	0.562988	1	0	0	no	0.8	0.6	no dnr	11	77	12.398438	120	25	38.59375	368	null	0.699951	1	136	7.419922	103	11	850	null	1	no(M2 and SIP pres)	1
2,612	68.08795	0	male	0	14	938	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	24,806	12,282.0547	14,048.6953	14.666664	null	23.699219	16	0.800903	0.735962	1	1	0	no	0.95	0.8	no dnr	14	55	12	98	10	36.09375	78.75	2.899902	1.299805	7.699219	135	7.349609	163	50	3,800	null	null	null	2.783203
2,613	79.51495	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	3	7	$11-$25k	44	38,930	17,790.625	24,372.1875	44	white	25.699219	39	0.344971	0.228973	13	0	0	yes	0.1	0.05	dnr after sadm	4	77	5.599609	70	35	38	204	null	null	0.699951	131	7.399414	168	19	948	null	null	<2 mo. follow-up	3.268555
2,614	42.62299	0	female	0	6	937	Lung Cancer	Cancer	1	13	null	0	7,367	4,045.7656	4,036.28906	11	white	14	11	0.803955	0.581909	1	0	0	metastatic	0.99	0.8	no dnr	6	57	19.796875	70	20	36.09375	433.3125	2.199707	0.5	1.399902	142	7.479492	93	41	null	2	3	null	3
2,615	83.99695	0	male	0	6	937	CHF	COPD/CHF/Cirrhosis	5	7	under $11k	0	7,790	4,020.8164	4,064.10938	14	white	21.796875	29	0.715942	0.557983	1	1	0	yes	null	null	no dnr	6	47	21	134	10	34.79688	62	2	0.199982	2.299805	136	7.399414	165	34	2,948	1	0	no(M2 and SIP pres)	0
2,616	33.89697	0	male	0	24	936	Coma	Coma	1	null	null	0	46,364	30,283.7969	29,555.2969	30.666656	white	19.699219	19	0.895996	0.875	1	0	0	no	null	null	no dnr	24	47	8.599609	100	20	36.09375	null	4	1.599854	0.799927	135	7.439453	107	15	1,100	null	null	null	1.926514
2,617	71.51495	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	18,491	8,120.4453	14,476.6094	14.5	white	21.898438	77	0.791992	0.723999	3	0	0	no	0.75	0.3	dnr after sadm	1	77	9.298828	80	25	36.69531	null	2.799805	3.699707	1.199951	127	null	197	28	800	null	2	<2 mo. follow-up	2
2,618	82.87994	1	male	0	8	225	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	8,872	4,778.4258	4,944.73828	14.5	white	19.097656	39	0.776978	0.644897	1	0	0	no	0.9	0.6	dnr after sadm	1	103	6.199219	49	24	38.39844	152.5	3.099609	9.199219	0.5	149	7.399414	331	15	1,260	null	null	no(M2 and SIP pres)	3.818848
2,619	31.806	0	female	0	13	929	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	21,303	8,634.6562	12,423.125	16	black	27.699219	39	0.858887	0.809937	1	0	0	no	0.95	0.95	no dnr	13	71	11.5	84	16	38.39844	null	2.399902	0.299988	0.699951	131	null	134	9	1,800	1	0	null	0
2,620	83.995	0	male	0	5	929	CHF	COPD/CHF/Cirrhosis	2	12	null	0	4,725	2,720.9766	2,598.51953	7	white	18.097656	33	0.822998	0.711914	1	0	0	no	0.8	0.7	no dnr	5	60	23	60	30	38.19531	178.3125	2.099609	null	1	129	7.449219	276	17	2,495	null	1	no(M2 and SIP pres)	1
2,621	43.64398	1	male	1	15	15	Cirrhosis	COPD/CHF/Cirrhosis	4	12	under $11k	0	61,249	20,110.8438	41,584.375	40.333313	white	31.796875	30	0.651978	0.473999	3	0	0	no	0.3	0.3	dnr after sadm	14	100	6.799805	80	20	37.19531	478.3125	3.299805	0.199982	1.099854	137	7.419922	189	19	1,150	null	0	<2 mo. follow-up	0
2,622	54.103	0	male	0	66	928	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	149,841	64,629.4375	104,043.75	23	white	28.898438	40	0.707886	0.618896	11	0	0	no	0.3	0.3	no dnr	66	63	13.5	70	20	36.59375	null	1.799805	6.5	2.799805	137	null	132	82	980	2	1	SIP>=30	1
2,623	60.40799	1	male	0	3	342	CHF	COPD/CHF/Cirrhosis	6	11	$25-$50k	0	3,982	2,106.6113	1,150.20996	null	white	19.796875	22	0.875977	0.793945	1	0	0	no	0.9	0.75	no dnr	3	62	9.798828	55	28	36.39844	121.65625	2.899902	null	1.199951	137	7.469727	123	25	1,905	0	null	no(M2 and SIP pres)	0.494751
2,624	83.56195	0	female	0	8	926	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	37,685	18,763.4062	20,545.7031	12.5	white	20.699219	22	0.701904	0.612915	4	0	0	yes	0.8	0.7	no dnr	8	63	10.298828	97	28	38.29688	136.71875	null	null	0.399963	136	7.469727	88	12	920	2	2	no(M2 and SIP pres)	2
2,625	82.35999	0	male	0	10	925	ARF/MOSF w/Sepsis	ARF/MOSF	1	24	>$50k	0	56,254	30,071.8281	38,469.7812	22.5	white	29	25	0.541992	0.427979	13	0	0	no	0.9	0.7	no dnr	10	110	14.798828	67	24	36.09375	173.3125	4.099609	0.599976	1.899902	135	7.369141	88	35	2,380	null	0	no(M2 and SIP pres)	0
2,626	61.90598	1	male	0	26	28	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$11-$25k	0	43,792	18,118.8438	21,882	14.75	white	23.398438	57	0.824951	0.765991	1	0	0	no	0.9	0.7	no dnr	26	81	7.099609	116	24	38	144.875	null	null	0.799927	134	7.479492	185	7	1,850	1	1	<2 mo. follow-up	1
2,627	54.784	0	female	0	4	922	Lung Cancer	Cancer	1	12	$11-$25k	0	15,991	7,817.5508	3,487.22852	13	white	2	16	0.911987	0.795898	1	0	0	metastatic	0.8	0.5	no dnr	4	113	15.5	126	38	36.29688	230	2	null	0.599976	142	7.429688	231	7	1,421	0	0	no(M2 and SIP pres)	0
2,628	74.85297	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$11-$25k	100	44,102	15,078.0781	27,142.5781	10	white	44.796875	84	0.001	0	7	0	0	no	0	0	dnr after sadm	2	77	8.099609	76	18	36.79688	null	3.399902	0.399963	1	142	null	100	7	3,250	null	null	<2 mo. follow-up	4.283203
2,629	73.18799	1	female	0	28	753	CHF	COPD/CHF/Cirrhosis	4	12	null	0	45,490	24,600.6406	25,142.2188	8.75	white	20.097656	52	0.834961	0.72998	1	1	0	no	0.8	0.8	no dnr	28	77	7.099609	50	25	36.09375	261.875	null	0.899902	1.599854	145	7.439453	114	25	null	1	5	SIP>=30	5
2,630	54.16599	0	female	0	75	919	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	193,965	73,248.25	128,066.688	38.5	white	25.796875	43	0.817993	0.756958	1	0	0	no	0.5	0.5	no dnr	75	77	14.099609	108	22	38.69531	212.5	2.899902	1.899902	0.899902	142	7.419922	100	27	1,875	null	0	adl>=4 (>=5 if sur)	0
2,631	81.97095	0	male	0	41	919	ARF/MOSF w/Sepsis	ARF/MOSF	1	3	null	0	141,760	122,821.688	120,521.125	24.75	white	19.699219	51	0.747925	0.667969	17	0	0	no	0.8	0.8	no dnr	41	131	18	66	4	38.39844	379	3.099609	1.099854	11.298828	137	7.229492	135	72	375	null	null	no(M2 and SIP pres)	2.303711
2,632	95.05298	1	male	0	12	873	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	under $11k	0	20,485	7,978.0625	15,630.6328	20	white	26.398438	41	0.588989	0.47998	3	0	0	no	0.05	0.05	no dnr	12	67	6.099609	80	25	36.09375	188	null	null	1.299805	142	7.349609	103	24	2,250	6	0	no(M2 and SIP pres)	0
2,633	89.84796	0	male	0	42	918	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	9	50,121	27,595.3594	34,923.2812	6	white	16.296875	24	0.767944	0.692993	6	1	1	no	0.2	0.1	dnr before sadm	0	59	22.097656	132	34	37.59375	142.84375	4.199219	0.399963	0.899902	137	7.399414	153	10	1,450	null	null	null	5.825195
2,634	20.821	0	male	0	19	917	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	$25-$50k	0	92,095	73,341.125	32,757.2656	26.333328	white	20.796875	38	0.922974	0.894897	3	0	0	no	0.8	0.8	no dnr	19	73	4.899414	70	25	36.09375	390.4375	null	null	1.5	141	7.5	103	35	800	null	6	adl>=4 (>=5 if sur)	6
2,635	76.91699	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	4	5	$11-$25k	9	10,552	4,853.0273	7,077.19922	7.5	black	20.097656	60	0.799927	0.733887	1	1	1	no	0.1	0	dnr after sadm	2	113	6.299805	43	12	36.19531	105	null	3.299805	0.699951	144	7.5	145	14	3,660	null	6	<2 mo. follow-up	6
2,636	85.336	1	male	0	11	110	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	9	12,972	7,308.043	6,891.02734	18.5	white	18.5	22	0.744995	0.5979	1	0	0	no	null	null	dnr before sadm	-1	73	15.599609	135	28	40.19531	230	2.099609	0.399963	0.5	158	7.379883	148	3.299805	1,870	null	3	adl>=4 (>=5 if sur)	3
2,637	87.75397	1	male	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	under $11k	0	53,522	34,284.5938	32,349.7969	49	white	31.898438	63	0.359985	0.241974	7	0	0	yes	0.1	0.05	dnr after sadm	1	76	20.796875	70	28	36.09375	null	3	null	1.099854	141	null	116	21	null	null	0	<2 mo. follow-up	0
2,638	70.28894	1	male	1	3	3	MOSF w/Malig	ARF/MOSF	4	null	null	0	24,749	13,033.4609	11,678.7031	59	white	57.195313	91	0.001	0	1	1	0	metastatic	null	null	dnr after sadm	2	122	13.599609	71	24	38.19531	144.875	null	null	0.699951	141	7.509766	116	32	3,066	null	null	<2 mo. follow-up	2.754883
2,639	60.40198	0	female	0	5	912	COPD	COPD/CHF/Cirrhosis	1	11	under $11k	0	5,828	3,155.9629	3,686.91992	12	black	15.298828	18	0.918945	0.862915	1	0	0	no	0.99	0.99	no dnr	5	50	12.199219	61	28	38.09375	143.3125	2.599609	1.899902	1	138	7.439453	112	9	5,625	0	null	no(M2 and SIP pres)	0.494751
2,640	74.11597	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	44	55,886	33,183.25	38,731.0312	39	white	18.097656	31	0.649902	0.550903	3	0	0	yes	0.2	0.1	dnr after sadm	10	62	8.699219	64	12	37.79688	376.1875	1.799805	11.699219	1.599854	138	7.399414	98	37	null	null	null	<2 mo. follow-up	3.237793
2,641	87.633	1	male	0	34	181	COPD	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	56,611	29,262.4375	27,387.3281	13.25	white	15.5	20	0.698975	0.534912	1	0	0	metastatic	0.9	0.75	no dnr	34	83	3.5	80	30	37	null	4.599609	0.399963	0.899902	138	null	91	9	4,900	null	2	SIP>=30	2
2,642	83.08295	1	female	1	4	4	Coma	Coma	2	12	under $11k	0	5,078	1,799.9971	4,726.70703	8	white	14.798828	22	0.685913	0.629883	1	0	0	yes	0	0	dnr after sadm	1	34	18.398438	41	8	35.39844	238	null	null	2.399902	137	7.399414	292	27	340	null	1	<2 mo. follow-up	1
2,643	78.63898	1	female	0	14	140	Lung Cancer	Cancer	2	12	null	0	23,239	11,915.2344	16,760.0312	10	white	7.299805	25	0.836914	0.642944	1	0	0	metastatic	0.8	0.4	dnr after sadm	1	70	5.399414	80	25	36.09375	233.3125	3.699707	0.599976	6.699219	139	7.319336	201	83	3,105	0	0	no(M2 and SIP pres)	0
2,644	91.92297	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	27,153	7,410.3867	22,544.9375	40.5	white	28.699219	32	0.590942	0.481995	1	0	0	no	null	null	dnr after sadm	2	141	22.097656	123	34	38	155	3.299805	0.599976	0.799927	141	7.5	172	13	1,730	null	2	<2 mo. follow-up	2
2,645	79.01196	1	male	0	9	337	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	null	0	18,246	13,885.0781	13,115.5078	20.5	white	19.898438	34	0.773926	0.700928	1	0	0	yes	1	1	no dnr	9	63	8.298828	80	30	37.79688	257.125	2.199707	null	3.899902	142	7.339844	207	116	1,720	0	0	adl>=4 (>=5 if sur)	0
2,646	31.82999	1	male	0	6	394	CHF	COPD/CHF/Cirrhosis	3	15	under $11k	0	8,811	5,220.5625	3,264.34961	20	white	21	30	0.924927	0.872925	1	0	0	no	0.85	0.75	no dnr	6	115	14	120	28	38.29688	null	null	null	6.299805	138	null	102	83	3,330	0	null	no(M2 and SIP pres)	0.494751
2,647	66.06995	1	male	0	6	62	Lung Cancer	Cancer	1	9	null	0	9,945	6,046.1016	8,137.56641	13	white	25.597656	16	0.494995	0.174988	1	0	0	metastatic	0.8	0.4	no dnr	6	76	5.899414	80	24	36.69531	null	3.399902	2	1	143	null	110	15	410	2	0	null	0
2,648	68.75299	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	null	null	null	39	white	37.398438	74	0.379944	0.261963	22	0	0	no	0.1	0.1	no dnr	8	110	7.699219	120	34	37.79688	224	1.899902	0.699951	0.5	135	7.449219	137	5	3,565	null	1	<2 mo. follow-up	1
2,649	91.81696	1	female	0	9	315	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	under $11k	9	13,455	5,766.6562	10,643.75	13.5	white	20.597656	37	0.714966	0.628906	2	1	1	no	0.85	0.5	dnr after sadm	3	68	11.599609	70	28	37.69531	342.8125	3.599609	1.099854	13.099609	152	7.439453	151	178	241	null	7	adl>=4 (>=5 if sur)	7
2,650	71.59796	1	female	0	18	532	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	0	36,646	14,415.6328	23,589.1562	19	black	21.097656	40	0.817993	0.704956	1	0	0	no	0.9	0.8	no dnr	18	67	20.199219	100	40	38.29688	null	null	0.5	1	139	null	161	14	null	1	3	no(M2 and SIP pres)	3
2,651	40.60199	0	male	0	11	904	Cirrhosis	COPD/CHF/Cirrhosis	6	12	under $11k	0	11,743	6,783.0039	6,489.71875	8.5	black	18.699219	18	0.887939	0.813965	1	0	0	no	0.6	0.4	dnr after sadm	5	60	8.699219	120	14	34.29688	158	1.799805	null	1.699951	132	7.40918	215	50	2,535	null	null	SIP>=30	3.787598
2,652	55.85199	0	female	0	110	903	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	0	340,910	190,980.5	237,194.25	32.75	white	19	34	0.887939	0.8479	1	0	0	no	0.8	0.8	no dnr	110	33	0.5	150	12	38.69531	60	4.199219	1.199951	1.699951	140	7.319336	159	22	450	null	null	no(M2 and SIP pres)	1.932861
2,653	64.51495	0	male	0	11	901	Lung Cancer	Cancer	3	null	null	0	14,429	8,822.6641	8,022.30859	11	white	15	13	0.747925	0.485962	1	0	0	metastatic	null	null	no dnr	11	113	7.5	70	25	36.69531	280.9375	null	null	1	141	7.369141	153	19	null	null	null	null	3.121094
2,654	67.409	0	male	0	13	900	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	null	0	49,973	null	null	25.5	white	19.5	26	0.780884	0.708984	6	1	0	yes	0.8	0.8	no dnr	13	68	9.398438	74	8	38.09375	145	2.099609	null	1.299805	144	7.5	123	30	3,263	0	0	no(M2 and SIP pres)	0
2,655	77.74695	0	female	0	4	898	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	3,228	1,775.8408	1,782.64941	11	white	19.898438	28	0.822998	0.711914	1	1	0	no	0.8	0.6	no dnr	4	80	16.699219	80	20	36.09375	261.875	3.899902	0.799927	1.5	140	7.339844	80	35	null	null	null	no(M2 and SIP pres)	2.09668
2,656	85.91895	1	female	0	15	133	CHF	COPD/CHF/Cirrhosis	4	16	>$50k	0	16,137	9,039.2656	8,929.63281	6	white	21.898438	36	0.759888	0.618896	1	1	1	no	0.7	0.5	dnr after sadm	2	103	9.599609	80	20	38.89844	402	null	null	1.5	137	7.439453	170	25	1,885	null	3	adl>=4 (>=5 if sur)	3
2,657	40.17499	0	female	0	6	898	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	0	9,842	4,744.2148	7,251.03906	14	white	15.798828	6	0.93396	0.909912	1	0	0	no	0.9	0.9	no dnr	6	76	5.099609	64	12	36.39844	null	4.299805	0.299988	1.099854	137	null	93	23	null	0	1	no(M2 and SIP pres)	1
2,658	78.448	1	female	0	10	315	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	19,295	9,187.2734	8,324.23438	21.5	white	16.097656	34	0.863892	0.815918	1	1	0	no	0.6	0.4	no dnr	10	49	13.099609	117	8	38.29688	198	2.5	0.799927	0.799927	134	7.429688	93	11	2,277	null	null	SIP>=30	2.557617
2,659	85.55798	1	female	1	5	5	CHF	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	12,845	4,185.3398	8,544.5	36	white	36.09375	51	0.246979	0.08699	1	1	0	metastatic	0.2	0.1	dnr after sadm	3	113	15.699219	70	14	39.09375	409.5	null	null	2.099609	136	7.399414	281	38	1,270	null	6	<2 mo. follow-up	6
2,660	86.89398	1	female	0	31	404	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	null	44	50,008	25,600.2812	28,714.0781	18.75	white	17.097656	36	0.658936	0.560913	4	1	0	no	null	null	dnr after sadm	8	80	10.298828	110	30	36.09375	237.5	3.799805	1.099854	1.399902	135	7.449219	87	24	1,879	null	null	adl>=4 (>=5 if sur)	4.15332
2,661	67.26099	1	male	1	7	7	Lung Cancer	Cancer	2	null	null	0	17,966	9,470.0312	8,934.44531	22	white	40.398438	77	0.093994	0.003	1	0	0	metastatic	null	null	dnr after sadm	5	100	24.699219	80	25	36.09375	436	3.199707	null	1	129	7.429688	124	14	null	null	null	<2 mo. follow-up	2.729492
2,662	68.94696	1	male	0	7	133	MOSF w/Malig	ARF/MOSF	2	8	$11-$25k	0	16,339	8,028.6094	11,330.0234	16	black	28.898438	42	0.497986	0.380981	1	0	0	metastatic	0.8	0.6	no dnr	7	70	12.199219	120	10	36.29688	96.25	2.299805	0.799927	4.899414	132	7.219727	103	50	0	7	4	no(M2 and SIP pres)	4
2,663	74.92999	1	male	0	4	48	Lung Cancer	Cancer	1	7	null	0	6,121	3,628.7383	5,463.69922	5	white	21.597656	18	0.576904	0.255981	1	0	0	metastatic	null	0.1	no dnr	4	65	10.599609	56	30	38.69531	183.65625	2.399902	null	1.099854	135	7.389648	306	28	1,350	0	3	<2 mo. follow-up	3
2,664	85.99298	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	10,742	4,711.6367	6,813.66797	14.5	white	26.097656	34	0.682983	0.588989	1	0	0	no	0.2	0.1	dnr after sadm	2	67	13.5	60	6	38.79688	136.65625	4.099609	0.799927	2	142	7.419922	157	24	645	null	0	<2 mo. follow-up	0
2,665	87.82196	1	female	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	null	0	32,606	13,760.4141	24,916.1562	31	white	41	55	0.17099	0.085999	10	0	0	no	0.2	0.2	dnr after sadm	3	83	3.899902	80	20	36.09375	null	1.5	1.699951	0.899902	129	null	125	11	null	null	6	<2 mo. follow-up	6
2,666	88.53699	1	female	0	16	82	CHF	COPD/CHF/Cirrhosis	2	16	>$50k	100	26,190	17,459.5625	17,609.0781	17	white	23.898438	35	0.237	0.080994	1	0	0	no	0.7	0.7	dnr after sadm	10	110	8.5	110	14	38.39844	314	2.799805	0.399963	0.5	150	7.339844	300	25	1,335	1	4	null	4
2,667	63.064	1	female	0	5	865	COPD	COPD/CHF/Cirrhosis	2	14	$11-$25k	0	4,934	2,945.0371	3,347.66992	9	white	22.597656	27	0.844971	0.745972	1	0	0	no	1	0.98	no dnr	5	80	6.099609	100	20	37.39844	null	null	0.399963	1	136	null	111	10	600	2	null	no(M2 and SIP pres)	1.838867
2,668	71.15094	1	female	0	100	833	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	0	179,736	94,621.375	113,885.5	22.75	white	21.699219	38	0.758911	0.681885	15	1	0	no	0.9	0.9	no dnr	100	105	9.898438	102	24	38.5	171.40625	2.599609	1.199951	1.199951	137	7.5	200	24	3,400	null	null	adl>=4 (>=5 if sur)	3.098145
2,669	41.16098	1	female	0	10	214	MOSF w/Malig	ARF/MOSF	2	12	$25-$50k	0	21,183	8,702.5938	12,183.8672	17	white	31.898438	53	0.464966	0.345947	1	0	0	metastatic	0.5	0.2	dnr after sadm	3	73	9.599609	60	20	36.09375	358.3125	null	null	1.799805	137	7.349609	222	30	1,850	0	1	no(M2 and SIP pres)	1
2,670	45.43198	0	female	0	23	886	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	123,970	67,890.6875	71,768.625	25.333328	black	32.5	42	0.677979	0.582886	10	0	0	no	0.95	0.95	no dnr	23	100	15.099609	80	20	38.29688	626.625	null	0.599976	3.899902	132	7.359375	277	86	950	null	null	null	2.731934
2,671	91.13794	1	female	0	5	407	CHF	COPD/CHF/Cirrhosis	4	null	under $11k	9	5,236	2,960.1621	3,021.78906	7	white	17	18	0.789917	0.661987	1	0	1	no	0.4	0.2	dnr before sadm	-1	117	5.599609	72	20	38.19531	218.3125	3.699707	0.399963	0.899902	133	7.349609	85	10	2,100	null	null	null	6.092773
2,672	81.13599	0	female	0	36	885	CHF	COPD/CHF/Cirrhosis	3	12	null	0	38,685	22,244.0469	21,736	7.5	white	14.398438	24	0.841919	0.740967	1	0	0	yes	0.8	0.7	dnr after sadm	2	60	9.798828	62	24	38.39844	480	2.699707	1.799805	1.199951	149	7.449219	719	63	700	1	0	null	0
2,673	58.349	1	female	0	11	158	MOSF w/Malig	ARF/MOSF	1	14	$11-$25k	0	12,365	5,889.5469	10,857.9688	14.5	white	18.796875	9	0.748901	0.669922	1	0	0	metastatic	0.9	0.5	no dnr	11	53	8.898438	96	33	35.79688	136.71875	2.599609	1.599854	1.899902	138	7.419922	187	41	1,855	0	0	no(M2 and SIP pres)	0
2,674	90.48596	1	female	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	14,422	5,378.875	11,185.9844	20.5	white	26.898438	46	0.642944	0.541992	1	0	0	no	null	null	dnr before sadm	-1	133	9.298828	82	24	36.79688	432	null	0.5	1.799805	147	7.379883	247	29	1,435	null	3	<2 mo. follow-up	3
2,675	45.95798	0	male	0	15	882	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	>$50k	0	31,723	21,983.0938	24,126.875	23.666656	white	21.097656	31	0.861938	0.813965	1	0	0	yes	0.7	0.5	no dnr	15	111	0.099991	140	28	36.29688	380	2	0.799927	3.5	142	7.359375	235	69	2,250	0	0	no(M2 and SIP pres)	0
2,676	78.58698	0	male	0	24	879	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	under $11k	0	31,302	15,784.8203	10,890.2734	24.666656	white	38.5	68	0.406982	0.286987	1	1	1	no	0.8	0.5	dnr before sadm	-1	80	2.299805	68	16	36.09375	556	2.299805	2.399902	2	154	7.459961	90	33	1,920	null	7	adl>=4 (>=5 if sur)	7
2,677	53.12799	0	female	0	45	879	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	44	92,751	57,897	61,964.25	15	black	23.199219	38	0.670898	0.574951	10	0	0	no	0.9	0.9	no dnr	45	76	11.798828	72	16	36.5	null	3.099609	0.399963	1.099854	138	null	127	22	null	0	0	no(M2 and SIP pres)	0
2,678	82.04797	0	female	0	9	879	CHF	COPD/CHF/Cirrhosis	6	6	under $11k	0	16,409	12,120.5391	12,838.2734	30.5	white	28.699219	39	0.570923	0.376953	1	0	0	yes	0.85	0.85	no dnr	9	107	18.199219	68	30	36.69531	null	3.099609	1.099854	3.699707	150	null	179	99	2,003	0	null	no(M2 and SIP pres)	0.494751
2,679	47.95297	1	female	1	7	7	Lung Cancer	Cancer	1	12	$11-$25k	0	12,930	6,180.0547	6,376.09766	20	black	17.5	17	0.736938	0.469971	1	0	0	metastatic	0.1	0.1	dnr after sadm	2	51	7.099609	50	6	35.59375	74	null	null	3	135	7.339844	72	105	1,024	0	0	<2 mo. follow-up	0
2,680	73.758	0	female	0	14	877	ARF/MOSF w/Sepsis	ARF/MOSF	3	10	under $11k	0	46,212	15,088.2344	33,754.7812	25	white	25.5	40	0.62793	0.523926	7	0	0	yes	0.6	0.6	dnr after sadm	8	61	11.199219	62	24	38.29688	120	3.799805	null	2.299805	138	7.419922	142	43	1,072	null	1	no(M2 and SIP pres)	1
2,681	88.23297	0	female	0	5	877	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	8,650	3,403.5019	6,157.62891	19	white	23.097656	22	0.73291	0.649902	1	0	0	no	1	0.95	no dnr	5	83	11.398438	100	25	36.09375	null	null	null	1.599854	135	null	97	47	2,100	0	null	no(M2 and SIP pres)	0.494751
2,682	61.74899	1	male	1	3	3	MOSF w/Malig	ARF/MOSF	1	13	$25-$50k	0	13,353	6,758.6875	7,565.27734	20	white	28.097656	54	0.45697	0.337952	6	0	0	metastatic	null	null	dnr after sadm	1	73	12.898438	100	24	37.39844	363.25	2.399902	null	2.099609	135	7.389648	234	37	1,145	null	null	<2 mo. follow-up	2.373047
2,683	88.00299	1	female	0	76	89	Coma	Coma	1	14	under $11k	44	102,276	55,993.5	18,285.5156	20.5	white	13.699219	17	0.555908	0.487976	1	0	1	no	0.5	0.3	dnr after sadm	27	57	0.799927	128	36	39.39844	328	2.599609	0.599976	0.799927	136	7.489258	112	10	2,100	null	1	null	1
2,684	76.92798	1	female	0	7	135	Lung Cancer	Cancer	1	12	null	0	14,385	6,852.5547	8,700.625	4.5	white	22.296875	35	0.552979	0.22998	1	0	0	metastatic	0.9	0.6	no dnr	7	50	21	110	8	38.19531	195	null	null	2.899902	141	7.40918	68	17	2,100	null	null	no(M2 and SIP pres)	2.375
2,685	67.31299	1	female	0	9	590	COPD	COPD/CHF/Cirrhosis	3	11	under $11k	9	13,149	5,712.6484	9,494.33594	15.5	white	14.298828	29	0.893921	0.821899	1	0	0	no	0.8	0.65	no dnr	9	67	8.099609	60	15	36.09375	403.3125	null	null	1.299805	139	7.359375	119	21	null	null	0	no(M2 and SIP pres)	0
2,686	76.14197	0	female	0	6	875	COPD	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	7,858	4,060.5547	4,837.07812	7	white	15.5	18	0.861938	0.771973	1	0	0	no	1	1	no dnr	6	70	16.398438	80	30	37	null	4	0.899902	0.899902	134	null	111	8	1,050	1	null	no(M2 and SIP pres)	1.166748
2,687	66.63898	1	female	0	6	163	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	7,222	3,841.3008	1,428.11914	7	black	12	13	0.922974	0.868896	1	1	0	no	null	null	no dnr	6	71	3.699707	74	20	38.09375	419	null	null	0.599976	139	7.449219	101	3	3,900	0	0	null	0
2,688	79.50696	1	female	0	4	207	CHF	COPD/CHF/Cirrhosis	4	14	$11-$25k	0	4,092	2,277.5312	1,371.8291	8	white	20.898438	36	0.80188	0.679932	1	1	0	no	0.9	0.8	no dnr	4	52	13.599609	107	24	37.79688	230.59375	3.399902	null	2	141	7.40918	388	52	1,780	0	null	no(M2 and SIP pres)	0.494751
2,689	44.06299	1	male	0	10	193	MOSF w/Malig	ARF/MOSF	1	13	$11-$25k	0	106,706	53,907.25	59,940.9688	25.5	black	37.09375	43	0.261963	0.155975	27	0	0	yes	0.75	0.5	no dnr	10	56	7.399414	117	8	38.09375	442.5	null	null	1	138	7.439453	97	12	2,111	1	null	no(M2 and SIP pres)	1.166748
2,690	54.56497	1	female	1	27	27	Coma	Coma	3	13	>$50k	0	90,807	75,018.625	77,704.5	42	white	28.699219	48	0.598999	0.534912	6	0	0	no	0.01	0.01	no dnr	27	49	15.599609	70	24	40.09375	120	3.099609	0.5	2.799805	156	7.199219	355	85	1,980	null	0	<2 mo. follow-up	0
2,691	70.49097	0	male	0	37	873	ARF/MOSF w/Sepsis	ARF/MOSF	4	11	null	0	129,379	49,179.8125	84,771.6875	36.25	white	24.796875	31	0.73291	0.649902	5	1	0	no	0.5	0.4	no dnr	37	113	21.796875	120	34	38.79688	293.875	null	null	0.799927	148	7.519531	150	10	1,265	null	0	no(M2 and SIP pres)	0
2,692	50.12997	1	male	0	32	272	MOSF w/Malig	ARF/MOSF	2	12	null	0	103,700	53,768.3438	50,489	28.5	other	35.09375	48	0.33197	0.21698	12	0	0	yes	0.7	0.5	no dnr	32	45	10.699219	75	14	38	363.3125	null	1.299805	2.699707	141	7.619141	173	47	3,105	0	1	no(M2 and SIP pres)	1
2,693	76.85699	1	female	0	16	456	ARF/MOSF w/Sepsis	ARF/MOSF	3	16	$11-$25k	0	26,843	12,188.6875	17,197.6719	11.333328	white	20.898438	20	0.786987	0.717896	3	0	0	no	0.8	0.8	no dnr	16	69	11.798828	100	24	36.59375	null	3.599609	0.699951	0.699951	137	null	129	7	1,800	1	0	SIP>=30	0
2,694	67.42499	1	female	0	15	252	Colon Cancer	Cancer	1	12	$11-$25k	0	20,324	11,267.1641	14,598.3672	14	white	22.199219	12	0.728882	0.45697	1	0	0	metastatic	0.93	0.7	no dnr	15	53	10.298828	113	14	38.29688	166.65625	2.099609	null	0.899902	138	7.379883	140	18	2,130	1	0	no(M2 and SIP pres)	0
2,695	76.19696	1	male	0	8	95	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	null	0	18,925	10,816.7031	11,470.0391	15.5	white	20.296875	64	0.762939	0.68689	2	0	0	yes	0.9	0.5	no dnr	8	127	15.298828	49	29	36.09375	286.625	3.599609	1.399902	0.799927	137	7.40918	136	15	2,210	5	null	adl>=4 (>=5 if sur)	3.854981
2,696	63.81699	0	female	0	14	869	COPD	COPD/CHF/Cirrhosis	3	16	under $11k	0	18,628	9,706.6719	11,663.5625	7	white	21.699219	26	0.851929	0.755981	1	0	0	no	0.8	0.8	dnr before sadm	-1	50	29.199219	110	32	36.59375	270	2.299805	null	1	145	7.289062	122	30	995	null	3	SIP>=30	3
2,697	76.01398	1	female	0	6	123	COPD	COPD/CHF/Cirrhosis	5	8	under $11k	0	8,725	4,444.0039	5,004.77734	19	white	21.796875	20	0.780884	0.649902	1	1	0	no	0.8	0.6	dnr before sadm	0	67	7.5	70	20	38.39844	663.25	null	null	0.699951	141	7.469727	89	16	750	4	5	SIP>=30	5
2,698	67.63898	0	female	0	11	868	COPD	COPD/CHF/Cirrhosis	2	18	null	0	17,103	8,721.7734	9,222.77344	13.5	white	17.898438	22	0.873901	0.790894	1	0	0	no	0.99	0.97	no dnr	11	70	12	80	25	36.69531	null	null	null	2.799805	137	null	104	66	null	1	null	no(M2 and SIP pres)	1.166748
2,699	44.58298	1	female	0	24	122	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	0	39,887	14,321.3672	30,776.1094	29.333328	black	29.296875	44	0.85791	0.765991	1	0	0	no	null	null	no dnr	24	71	16.699219	80	30	38.09375	260	3.799805	1.099854	1.299805	137	7.289062	166	26	3,500	null	null	no(M2 and SIP pres)	2.935059
2,700	73.42896	1	female	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	103,441	55,695.25	64,998.5	51	white	21.5	29	0.756958	0.679932	12	1	0	no	0.4	0.1	dnr after sadm	3	87	18.5	80	20	36.69531	488.3125	null	null	1.099854	138	7.359375	137	26	600	null	null	<2 mo. follow-up	2.218262

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.